Insider sale
LANTERN PHARMA INC.
$175.9K
53.45K shares
What this filing means
BIOS FUND II, LP plans to sell 53.45K shares of LANTERN PHARMA INC. valued at approximately $175.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2025ACC: 0001104659-25-053175
53.45K
Shares to sell
$175.9K
Approx. market value
221.52K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Conversion of Shares in IPO
Conversion
6/15/2020
221.52KTotal acquired221.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2020 | Conversion of Shares in IPO Conversion | 221.52K | — |
| Total | 221.52K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
53.45K
Market value
$175.9K
5/27/2025
Total
Units
53.45K
Value
$175.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/27/2025 | 53.45K | $175.9K | NASDAQ | Planned |
| Total | 53.45K | $175.9K | ||